Target intelligence / Profile preview

Ribosomal protein L26 pseudogene 8 (RPL26P8)

Target: RPL26P8
Molecular classification: Other (Pseudogene, non-coding)

Overview

Ribosomal protein L26 pseudogene 8 (RPL26P8) is a processed pseudogene of the ribosomal protein L26 gene, annotated in the human genome as ENSG00000227312 and also known as RPL26_1_22[1][2]. Like other ribosomal protein pseudogenes, it does not encode a functional protein and is considered non-coding, lacking known biological functions or disease associations. Pseudogenes such as RPL26P8 are typically regarded as relics of duplicated ancestral genes and are not considered canonical drug targets, receptors, or enzymes[5][6]. There is no evidence supporting a role as a biomarker, therapeutic target, or involvement with any drugs.

Other names: RPL26_1_22ENSG00000227312

Beyond the preview

Go deeper on Ribosomal protein L26 pseudogene 8 (RPL26P8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L26 pseudogene 8 (RPL26P8).

Explore the full profile